{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:04:03Z","timestamp":1790654643354,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","joms.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.joms.2020.10.005","type":"journal-article","created":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T13:13:36Z","timestamp":1602594816000},"page":"611-621","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["The Type of Antiresorptive Treatment Influences the Time to Onset and the Surgical Outcome of Medication-Related Osteonecrosis of the Jaw"],"prefix":"10.1016","volume":"79","author":[{"given":"Christoph","family":"Pautke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Wick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Otto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Hohlweg-Majert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Ristow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.joms.2020.10.005_bib1","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jcms.2014.11.014","article-title":"Treatment perspectives for medication-related osteonecrosis of the jaw (MRONJ)","volume":"43","author":"Ristow","year":"2015","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1016\/j.joms.2020.10.005_bib2","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1111\/odi.13160","article-title":"Workshop of European task force on medication-related osteonecrosis of the jaw-Current challenges","volume":"25","author":"Schiodt","year":"2019","journal-title":"Oral Dis"},{"key":"10.1016\/j.joms.2020.10.005_bib3","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.jcms.2018.05.046","article-title":"Osteonecrosis of the jaw in patients treated with denosumab: A multicenter case series","volume":"46","author":"Aljohani","year":"2018","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1016\/j.joms.2020.10.005_bib4","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00784-018-2443-9","article-title":"Comparison of mucosal and mucoperiosteal wound cover for the treatment of medication-related osteonecrosis of the jaw lesions: A retrospective cohort study","volume":"23","author":"Nonnenmuhlen","year":"2019","journal-title":"Clin Oral Investig"},{"key":"10.1016\/j.joms.2020.10.005_bib5","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s00432-010-0953-1","article-title":"Outcome of treatment and parameters influencing recurrence in patients with bisphosphonate-related osteonecrosis of the jaws","volume":"137","author":"Mucke","year":"2011","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.joms.2020.10.005_bib6","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.jcms.2016.05.018","article-title":"Fluorescence-guided surgery for the treatment of medication-related osteonecrosis of the jaw: A prospective cohort study","volume":"44","author":"Otto","year":"2016","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1016\/j.joms.2020.10.005_bib7","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ijom.2016.10.008","article-title":"Comparison of auto-fluorescence and tetracycline fluorescence for guided bone surgery of medication-related osteonecrosis of the jaw: A randomized controlled feasibility study","volume":"46","author":"Ristow","year":"2017","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2020.10.005_bib8","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jcms.2011.05.003","article-title":"Bisphosphonate-related osteonecrosis of the jaws - characteristics, risk factors, clinical features, localization and impact on oncological treatment","volume":"40","author":"Otto","year":"2012","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1016\/j.joms.2020.10.005_bib9","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1159\/000343950","article-title":"Incidence and risk factors of bisphosphonate-related osteonecrosis of the jaw in multiple myeloma patients having undergone autologous stem cell transplantation","volume":"35","author":"Then","year":"2012","journal-title":"Onkologie"},{"key":"10.1016\/j.joms.2020.10.005_bib10","first-page":"1905","article-title":"A multicenter case registry study on medication-related osteonecrosis of the jaw in patients with advanced cancer","volume":"26","author":"Schiodt","year":"2018","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.joms.2020.10.005_bib11","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1016\/j.joms.2010.07.017","article-title":"Osteonecrosis of the jaw: Effect of bisphosphonate type, local concentration, and acidic milieu on the pathomechanism","volume":"68","author":"Otto","year":"2010","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2020.10.005_bib12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.oooo.2017.09.014","article-title":"Rapid onset of osteonecrosis of the jaw in patients switching from bisphosphonates to denosumab","volume":"125","author":"Yarom","year":"2018","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.joms.2020.10.005_bib13","first-page":"2014","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update","volume":"72","author":"Ruggiero","year":"1938","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2020.10.005_bib14","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.joms.2008.09.037","article-title":"Fluorescence-guided bone resection in bisphosphonate-associated osteonecrosis of the jaws","volume":"67","author":"Pautke","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2020.10.005_bib15","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jcms.2018.03.005","article-title":"Double-layer closure techniques after bone surgery of medication-related osteonecrosis of the jaw - a single center cohort study","volume":"46","author":"Ristow","year":"2018","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1016\/j.joms.2020.10.005_bib16","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.ijom.2014.07.017","article-title":"Auto-fluorescence of the bone and its use for delineation of bone necrosis","volume":"43","author":"Ristow","year":"2014","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2020.10.005_bib17","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1080\/17843286.2017.1348001","article-title":"Incidence of osteonecrosis of the jaw in patients with bone metastases treated sequentially with bisphosphonates and denosumab","volume":"73","author":"Loyson","year":"2018","journal-title":"Acta Clin Belg"},{"key":"10.1016\/j.joms.2020.10.005_bib18","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/jop.12646","article-title":"Denosumab-related osteonecrosis of the jaw: A retrospective study","volume":"47","author":"Egloff-Juras","year":"2018","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.joms.2020.10.005_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/jbmr.4119","article-title":"A drug holiday reduces the frequency and severity of Medication Related Osteonecrosis of the jaw in a minipig model","author":"Otto","year":"2020","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.joms.2020.10.005_bib20","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.joms.2010.07.014","article-title":"Fluorescence-guided bone resection in bisphosphonate-related osteonecrosis of the jaws: First clinical results of a prospective pilot study","volume":"69","author":"Pautke","year":"2011","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2020.10.005_bib21","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.joms.2009.01.006","article-title":"The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws","volume":"67","author":"Carlson","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2020.10.005_bib22","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.bjoms.2014.01.021","article-title":"Effect of antiresorptive drugs on bony turnover in the jaw: Denosumab compared with bisphosphonates","volume":"52","author":"Ristow","year":"2014","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2020.10.005_bib23","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.joms.2013.11.005","article-title":"Is bone turnover of jawbone and its possible over suppression by bisphosphonates of etiologic importance in pathogenesis of bisphosphonate-related osteonecrosis?","volume":"72","author":"Ristow","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2020.10.005_bib24","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/COC.0b013e3182155fcb","article-title":"A retrospective study evaluating frequency and risk factors of osteonecrosis of the jaw in 576 cancer patients receiving intravenous bisphosphonates","volume":"35","author":"Thumbigere-Math","year":"2012","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.joms.2020.10.005_bib25","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/odi.12632","article-title":"Time to onset of bisphosphonate-related osteonecrosis of the jaws: A multicentre retrospective cohort study","volume":"23","author":"Fung","year":"2017","journal-title":"Oral Dis"},{"key":"10.1016\/j.joms.2020.10.005_bib26","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00784-017-2325-6","article-title":"Stage-specific therapeutic strategies of medication-related osteonecrosis of the jaws: A systematic review and meta-analysis of the drug suspension protocol","volume":"22","author":"Ramaglia","year":"2018","journal-title":"Clin Oral Investig"},{"key":"10.1016\/j.joms.2020.10.005_bib27","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s00774-019-01035-7","article-title":"Drug holiday clinical relevance verification for antiresorptive agents in medication-related osteonecrosis cases of the jaw","volume":"38","author":"Hayashida","year":"2020","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.joms.2020.10.005_bib28","doi-asserted-by":"crossref","first-page":"78","DOI":"10.5125\/jkaoms.2020.46.1.78","article-title":"The effect of bisphosphonate discontinuation on the incidence of postoperative medication-related osteonecrosis of the jaw after tooth extraction","volume":"46","author":"Kang","year":"2020","journal-title":"J Korean Assoc Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2020.10.005_bib29","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.jcms.2017.05.028","article-title":"What is the effect of anti-resorptive drugs (ARDs) on the development of medication-related osteonecrosis of the jaw (MRONJ) in osteoporosis patients: A systematic review","volume":"45","author":"Aljohani","year":"2017","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1016\/j.joms.2020.10.005_bib30","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.joms.2017.10.024","article-title":"Can Autofluorescence Guide surgeons in the treatment of medication-related osteonecrosis of the jaw? A prospective feasibility study","volume":"76","author":"Giudice","year":"2018","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2020.10.005_bib31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","article-title":"International task force on osteonecrosis of the J: Diagnosis and management of osteonecrosis of the jaw: A systematic review and international consensus","volume":"30","author":"Khan","year":"2015","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.joms.2020.10.005_bib32","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1200\/JCO.19.01186","article-title":"Medication-related osteonecrosis of the jaw: MASCC\/ISOO\/ASCO clinical Practice guideline","volume":"37","author":"Yarom","year":"2019","journal-title":"J Clin Oncol"}],"container-title":["Journal of Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278239120312210?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278239120312210?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T17:01:57Z","timestamp":1759510917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278239120312210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0278239120312210"],"URL":"https:\/\/doi.org\/10.1016\/j.joms.2020.10.005","relation":{},"ISSN":["0278-2391"],"issn-type":[{"value":"0278-2391","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Type of Antiresorptive Treatment Influences the Time to Onset and the Surgical Outcome of Medication-Related Osteonecrosis of the Jaw","name":"articletitle","label":"Article Title"},{"value":"Journal of Oral and Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joms.2020.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Association of Oral and Maxillofacial Surgeons","name":"copyright","label":"Copyright"}]}}